117 related articles for article (PubMed ID: 37114647)
21. Incidence trends of acute viral hepatitis caused by four viral etiologies between 1990 and 2019 at the global, regional and national levels.
Ouyang G; Pan G; Guan L; Wu Y; Lu W; Qin C; Li S; Xu H; Yang J; Wen Y
Liver Int; 2022 Dec; 42(12):2662-2673. PubMed ID: 36214561
[TBL] [Abstract][Full Text] [Related]
22. Secular trends of morbidity and mortality of thyroid cancer in five Asian countries from 1990 to 2019 and their predictions to 2035.
Tang SD; Zi H; Tao H; Huang Q; Guo XP; Deng T; Li F
Thorac Cancer; 2023 Dec; 14(36):3540-3548. PubMed ID: 37941298
[TBL] [Abstract][Full Text] [Related]
23. Temporal trends of tracheal, bronchus, and lung cancer between 2010 and 2019, in Asian countries by geographical region and sociodemographic index, comparison with global data.
Rezaei F; Mazidimoradi A; Rayatinejad A; Allahqoli L; Salehiniya H
Thorac Cancer; 2023 Jun; 14(18):1668-1706. PubMed ID: 37127553
[TBL] [Abstract][Full Text] [Related]
24. Global burden and trends of neglected tropical diseases from 1990 to 2019.
Lin Y; Fang K; Zheng Y; Wang HL; Wu J
J Travel Med; 2022 May; 29(3):. PubMed ID: 35238925
[TBL] [Abstract][Full Text] [Related]
25. Global trends in testicular cancer incidence and mortality.
Rosen A; Jayram G; Drazer M; Eggener SE
Eur Urol; 2011 Aug; 60(2):374-9. PubMed ID: 21612857
[TBL] [Abstract][Full Text] [Related]
26. Global burden of prostate cancer attributable to smoking among males in 204 countries and territories, 1990-2019.
Zhang H; Huang D; Zhang Y; Wang X; Wu J; Hong D
BMC Cancer; 2023 Jan; 23(1):92. PubMed ID: 36703189
[TBL] [Abstract][Full Text] [Related]
27. Secular trends of morbidity and mortality of prostate, bladder, and kidney cancers in China, 1990 to 2019 and their predictions to 2030.
Huang Q; Zi H; Luo L; Li X; Zhu C; Zeng X
BMC Cancer; 2022 Nov; 22(1):1164. PubMed ID: 36368976
[TBL] [Abstract][Full Text] [Related]
28. Global, Regional, and National Incidence and Mortality of Neonatal Preterm Birth, 1990-2019.
Cao G; Liu J; Liu M
JAMA Pediatr; 2022 Aug; 176(8):787-796. PubMed ID: 35639401
[TBL] [Abstract][Full Text] [Related]
29. Changes in the disease burden of breast cancer along with attributable risk factors in China from 1990 to 2019 and its projections: An analysis of the global burden of disease study 2019.
Li J; Chen C; Nie J; Wang L; Zhang Z; Li Y
Cancer Med; 2023 Jan; 12(2):1888-1902. PubMed ID: 35785526
[TBL] [Abstract][Full Text] [Related]
30. Global trends in the incidence and mortality of esophageal cancer from 1990 to 2017.
Fan J; Liu Z; Mao X; Tong X; Zhang T; Suo C; Chen X
Cancer Med; 2020 Sep; 9(18):6875-6887. PubMed ID: 32750217
[TBL] [Abstract][Full Text] [Related]
31. Mortality burden and future projections of major risk factors for esophageal cancer in China from 1990 to 2019.
Wu G; Wu Q; Xu J; Gao G; Chen T; Chen G
Gen Thorac Cardiovasc Surg; 2024 Mar; 72(3):192-201. PubMed ID: 37973657
[TBL] [Abstract][Full Text] [Related]
32. Lung cancer burden and trends from 2000 to 2018 in China: Comparison between China and the United States.
Teng Y; Xia C; Cao M; Yang F; Yan X; He S; Cao M; Zhang S; Li Q; Tan N; Wang J; Chen W
Chin J Cancer Res; 2023 Dec; 35(6):618-626. PubMed ID: 38204441
[TBL] [Abstract][Full Text] [Related]
33. Changing trends in the disease burden of non-melanoma skin cancer globally from 1990 to 2019 and its predicted level in 25 years.
Hu W; Fang L; Ni R; Zhang H; Pan G
BMC Cancer; 2022 Jul; 22(1):836. PubMed ID: 35907848
[TBL] [Abstract][Full Text] [Related]
34. Global, regional, and national trends in mesothelioma burden from 1990 to 2019 and the predictions for the next two decades.
Zhu W; Liu J; Li Y; Shi Z; Wei S
SSM Popul Health; 2023 Sep; 23():101441. PubMed ID: 37334331
[TBL] [Abstract][Full Text] [Related]
35. Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990-2019: A DALY-based analysis of the Global Burden of Disease 2019 study.
Choi S; Kim BK; Yon DK; Lee SW; Lee HG; Chang HH; Park S; Koyanagi A; Jacob L; Dragioti E; Radua J; Shin JI; Kim SU; Smith L
Clin Mol Hepatol; 2023 Apr; 29(2):433-452. PubMed ID: 36597018
[TBL] [Abstract][Full Text] [Related]
36. Burden of lung cancer along with attributable risk factors in China from 1990 to 2019, and projections until 2030.
Fang Y; Li Z; Chen H; Zhang T; Yin X; Man J; Yang X; Lu M
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3209-3218. PubMed ID: 35904601
[TBL] [Abstract][Full Text] [Related]
37. Variations in incidence and mortality rates of endometrial cancer at the global, regional, and national levels, 1990-2019.
Gu B; Shang X; Yan M; Li X; Wang W; Wang Q; Zhang C
Gynecol Oncol; 2021 May; 161(2):573-580. PubMed ID: 33551200
[TBL] [Abstract][Full Text] [Related]
38. Global incidence and mortality of hepatitis B and hepatitis C acute infections, cirrhosis and hepatocellular carcinoma from 2010 to 2019.
Veracruz N; Gish RG; Cheung R; Chitnis AS; Wong RJ
J Viral Hepat; 2022 May; 29(5):352-365. PubMed ID: 35274406
[TBL] [Abstract][Full Text] [Related]
39. Trends of the Global, Regional and National Incidence, Mortality, and Disability-Adjusted Life Years of Malaria, 1990-2019: An Analysis of the Global Burden of Disease Study 2019.
Shi D; Wei L; Liang H; Yan D; Zhang J; Wang Z
Risk Manag Healthc Policy; 2023; 16():1187-1201. PubMed ID: 37396933
[TBL] [Abstract][Full Text] [Related]
40. The Global, Regional, and National Burden and Trends of NAFLD in 204 Countries and Territories: An Analysis From Global Burden of Disease 2019.
Chen H; Zhan Y; Zhang J; Cheng S; Zhou Y; Chen L; Zeng Z
JMIR Public Health Surveill; 2022 Dec; 8(12):e34809. PubMed ID: 36508249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
